Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.3 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.048 | 0.3 |